Mirai Bio

The first open end-to-end platform for genetic medicines

Employees
11–50

About

Machine intelligence-based open platform for end-to-end genetic medicine development, enabling delivery to any tissue and cell type.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

View pricing

Similar Companies